A Non-Invasive Cervical Cancer Screening Modality: A Pilot Study

Stopped early · Not applicable

Conditions studied: Women With Abnormal Pap Smears

In brief

Cervix cancer is a major global health concern. A way to screen and immediately treat precancerous lesions (Screen-and-Treat) is greatly needed. Developed by MobileOCT, polarized difference imaging and conventional imaging are used to identify suspicious lesions. We aim to compare this non-invasive method with colposcopy. Patients at the Dickens Clinic will have 3-5 minutes of non-invasive imaging before colposcopy. Pathology will be compared both to colposcopy impression versus MobileOCT.

Key facts

Study ID

NCT02767726

Run by

Abramson Cancer Center at Penn Medicine

People needed

4

Starts

2016-01-01

Expected to finish

2017-04-01

Last updated by the study team

2020-05-13

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Subjects capable of giving informed consent or have an acceptable surrogate capable of giving consent on subjects behalf.
• Subjects are 18 years of age or older
• Subjects are scheduled for colposcopy clinic based on screening with abnormal pap smear or have repeat colposcopy indicated for specific clinical indications, based off of American Society of Cosposcopy and Cytology.
• Subjects are women.

You may not qualify if…

• Pregnancy.
• Males (males do not have a cervix and thus cannot undergo colposcopy).

Where it is running

• Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.